Peptides by goal · Healing, gut and immunity
Peptides for injury recovery and healing, ranked by evidence
Checked against our library and study pagesPublished by PepVault
Of the 16 compounds in our library linked to injury recovery and healing, 9 have been studied in people for it, 6 have animal or lab evidence only, and 1 rests on community reports alone. Teriparatide ranks first, with 3 of our study pages in people on injury recovery and healing.
Peptides and injury recovery and healing
Tendons, ligaments and muscles heal slowly, and the healing peptides are among the most used in the community. Most of what is known comes from animal injury models, such as a cut tendon in a rat; the human data so far are small and mostly uncontrolled.
For healing, look at what kind of injury a study used and in which animal: a surgically cut tendon in a rat heals differently from a long-running tendon problem in a person.

The 16 compounds, ranked by evidence
Studied in people
9 compounds
Teriparatide
#1 · Human studiesA daily shot of the active part of parathyroid hormone (Forteo) that builds new bone, rather than only slowing bone loss as most osteoporosis drugs do. Commonly reported: little day to day, sometimes joint pain, nausea, leg cramps or light-headedness after the first shots. For injury recovery and healing it has been studied in people: 3 of our study pages in people are about it.
Teriparatide cut fracture risk vs bisphosphonates (RR 0.61)Our study page: meta-analysis in people, 6,680 people, 2024
- Teriparatide: richer early callus in distal radial fractures
- Teriparatide: fewer new vertebral fractures than risedronate in VERO
Why it is here: 3 of our study pages are about this goal.
Abaloparatide
#2 · Human studiesA daily shot (Tymlos) that builds new bone, a close relative of teriparatide modelled on a different natural hormone, PTHrP. Some people with a bone injury run BPC-157 or TB-500 beside a prescribed bone-building drug, hoping the soft-tissue peptides help the tissue around it. For injury recovery and healing it has been studied in people: 2 of our study pages in people are about it.
Abaloparatide: fewer new vertebral fractures vs placebo in ACTIVEOur study page: randomized trial in people, 2,463 people, 2016
Why it is here: 2 of our study pages are about this goal.
LL-37
#3 · Human studiesYour body's own antimicrobial peptide. For injury recovery and healing it has been studied in people: 2 of our study pages in people are about it.
LL-37: no healing gain over placebo for venous leg ulcers overallOur study page: randomized trial in people, 148 people, 2021
Why it is here: its library entry lists “Wound healing” and 2 of our study pages are about this goal.
HGH
#4 · Human studiesRecombinant human growth hormone — an identical copy of the GH your pituitary makes. It stimulates IGF-1 production, fat burning, muscle protein synthesis and tissue repair. For injury recovery and healing it has been studied in people: 1 of our study pages in people is about it.
HGH: adult burn wounds healed 9.07 days faster in a meta-analysisOur study page: meta-analysis in people, 701 people, 2014
Why it is here: 1 of our study pages is about this goal.
MK-677
#5 · Human studiesNot actually a peptide — it's a small molecule you take orally that mimics ghrelin to stimulate GH release. For injury recovery and healing it has been studied in people: 1 of our study pages in people is about it.
MK-677 raised IGF-1 but not most function after hip fractureOur study page: randomized trial in people, 123 people, 2011
Why it is here: 1 of our study pages is about this goal.
BPC-157
#6 · Human studiesA peptide derived from a protective protein in your stomach. Commonly reported: faster recovery from tendon and ligament injuries, and a calmer gut. For injury recovery and healing it has been studied in people: 1 of our study pages in people is about it, beside 8 animal or lab studies (rats, mice and rat Achilles tendon fibroblasts).
BPC-157: 14 of 16 reported knee pain relief in a chart reviewOur study page: observational study in people, 17 people, 2021
- BPC-157: non-significant tendon gains in rats; TB-500 did better
- BPC-157 closed duodenocolic fistulas in rats
- BPC-157 reduced radiation liver injury in mice and rat liver cells
Why it is here: its library entry lists “Tissue repair” and “Tendon recovery” and 9 of our study pages are about this goal.
GHK-Cu
#7 · Human studiesA small copper-binding peptide found naturally in your blood and widely used in skincare. GHK-Cu brings the skin and collagen side; BPC-157 and TB-500 bring tendon, gut and wound repair. For injury recovery and healing it has been studied in people: 1 of our study pages in people is about it, beside 3 animal or lab studies (mice, rats and chick embryo chondrocytes).
GHK-Cu gel: 98.5% median closure of diabetic plantar ulcers vs 60.8%Our study page: randomized trial in people, 1994
- GHK-Cu liposomes sped scald wound healing in mice
- GHK-Cu increased collagen and tissue buildup in rat wound chambers
- GHK-Cu boosted growth of chick embryo cartilage cells in culture
Why it is here: its library entry lists “Wound healing” and 4 of our study pages are about this goal.
TB-500
#8 · Human studiesA fragment of thymosin beta-4, a protein your body uses for cell repair. Commonly reported: stubborn soft-tissue injuries loosening up, with range of motion returning over a few weeks. For injury recovery and healing it has been studied in people: 1 of our study pages in people is about it, beside 2 animal or lab studies (mice and rats).
TB-500 on venous ulcers: safety comparable to placebo in Phase 2Our study page: randomized trial in people, 73 people, 2010
- Thymosin beta-4 sped skin wound healing in diabetic and aged mice
- BPC-157: non-significant tendon gains in rats; TB-500 did better
Why it is here: its library entry lists “Cell migration”, “Wound repair”, “Tendon repair” and “Muscle recovery” and 3 of our study pages are about this goal.
Thymosin Beta-4
#9 · Human studiesThe full-length version of the protein TB-500 is cut from. Commonly reported: less nagging joint and soft-tissue pain and stiffness over a few weeks, and sometimes tiredness for a day after injecting. For injury recovery and healing the trials in people that its library entry cites put it on this rung; our 2 study pages on it for this goal are animal or lab studies (rats and mice).
The library’s research note “What full Tβ4 is built on” rests on studies in people.
Thymosin Beta-4 sped full thickness skin wound healing in ratsOur study page: animal study in rats, 1999
Why it is here: its library entry lists “Tissue repair” and 2 of our study pages are about this goal.
Animal or lab studies only
6 compounds
AOD-9604
#10 · Animal or labA modified fragment of human growth hormone that targets fat metabolism. Cartilage repair was seen in one rabbit study. For injury recovery and healing the evidence is from animals or cells only: 1 study page of ours, in rabbits.
AOD-9604 knee injections lowered cartilage damage in rabbitsOur study page: animal study in rabbits, 32 studied, 2015
Why it is here: its library entry lists “Cartilage support” and 1 of our study pages is about this goal.
ARA-290
#11 · Animal or labEleven amino acids copied from the water-facing side of one helix in erythropoietin, the hormone that drives red-cell production — residues that sit side by side on that face, strung into a new chain rather than a stretch cut out of the hormone. In rats with an injured nerve it reduced allodynia for weeks and damped the spinal microglia response. For injury recovery and healing the evidence is from animals or cells only: 1 study page of ours, in rats.
ARA-290 eased nerve-injury pain for up to 20 weeks in ratsOur study page: animal study in rats, 2014
Why it is here: 1 of our study pages is about this goal.
Dihexa
#12 · Animal or labAn experimental nootropic that increased new synaptic connections between neurons in rat studies from one lab. For injury recovery and healing the evidence is from animals or cells only: 1 study page of ours, in rats.
Dihexa plus stem cells improved rat motor function after nerve repairOur study page: animal study in rats, 2021
Why it is here: 1 of our study pages is about this goal.
SS-31
#13 · Animal or labA mitochondria-targeting peptide that binds directly to cardiolipin — a key lipid in the inner mitochondrial membrane where your cells generate energy. For injury recovery and healing the evidence is from animals or cells only: 1 study page of ours, in mice.
SS-31 aided functional recovery after spinal cord injury in miceOur study page: animal study in mice, 2023
Why it is here: 1 of our study pages is about this goal.
Cartalax
#14 · Animal or labA short peptide from the Russian bioregulator program behind Epitalon and Pinealon, which its developers describe as a bioregulator for cartilage and joints. In cell studies it raised the genes cartilage is built from in aging stem cells and damped the aging signals of cartilage cells, and in rats it slowed bone loss. For injury recovery and healing the evidence its library entry cites is from animal studies, and none of our study pages covers it yet.
The library’s research note “What Cartalax is built on” rests on animal studies.
Why it is here: its library entry lists “Joint comfort” and “Cartilage support”.
PEG-MGF
#15 · Animal or labWhen muscle is loaded or damaged, the IGF-1 gene can be read a different way, producing a variant with an extra tail. The 24-amino-acid tail of IGF-1Ec, a splice variant of the IGF-1 gene that muscle turns up after loading or injury; the tail is cut off when the gene product is processed, and that fragment is what is sold as mechano growth factor. For injury recovery and healing the evidence its library entry cites is from animal studies, and none of our study pages covers it yet.
The library’s research note “Multiply first, repair after” rests on animal studies.
Why it is here: its library entry lists “Muscle repair (animal data)”.
Community reports only
1 compound
Ac-SDKP
#16 · Reports onlyThe first four amino acids of thymosin beta-4, sold as a 'TB-500 fragment' though it isn't part of TB-500. In rodent studies it calms inflammation and scarring in the heart, kidneys and lungs and helps new blood vessels form; no study has looked at tendons or ligaments. For injury recovery and healing it rests on community reports: no study page of ours covers this goal, and the library lists it under “Soft-tissue recovery”.
Why it is here: its library entry lists “Soft-tissue recovery”.
How they differ
Route, dosing frequency and half-life as each library entry records them, for the 16 compounds in ranked order.
| Compound | Evidence | Route | Dosing frequency | Half-life |
|---|---|---|---|---|
| Teriparatide | Human studies | SubQ injection | Daily SubQ | ~1 hour |
| Abaloparatide | Human studies | SubQ injection | Daily SubQ | ~1 hour |
| LL-37 | Human studies | SubQ injection | Daily or EOD | Unknown in humans |
| HGH | Human studies | SubQ injection | Daily SubQ injection. | ~3-4 hours |
| MK-677 | Human studies | Oral | Daily, before bed | ~24 hours |
| BPC-157 | Human studies | SubQ injection, IM injection, Oral (less studied) | Once or twice daily | ~4–6 hours |
| GHK-Cu | Human studies | SubQ injection, Topical application, IM injection | Daily | Not measured in humans |
| TB-500 | Human studies | SubQ injection, IM injection | 2x/week loading, 1–2mg/week maintenance | ~0.5–2 hours |
| Thymosin Beta-4 | Human studies | SubQ injection, IM injection | Weekly | ~0.5–2 hours |
| AOD-9604 | Animal or lab | SubQ injection | Daily, fasted | ~30 min |
| ARA-290 | Animal or lab | SubQ injection | Daily | ~20 minutes |
| Dihexa | Animal or lab | Oral, Topical (DMSO carrier) | Daily (cycle 4–8 weeks) | Very long |
| SS-31 | Animal or lab | SubQ injection | Daily | Short |
| Cartalax | Animal or lab | SubQ injection, Oral capsules | Daily | Unknown |
| PEG-MGF | Animal or lab | SubQ injection, IM injection | 2–3x weekly, post-workout | Not measured: no pharmacokinetic study of PEG-MGF has been published, in people or in animals. The unmodified peptide is broken down quickly, and for a mouse heart study researchers stabilized it chemically — amidating one end and swapping two arginines for their mirror-image form |
| Ac-SDKP | Reports only | SubQ injection | EOD or twice weekly. | ~4.5 min |
- Evidence
- Human studies
- Route
- SubQ injection
- Dosing
- Daily SubQ
- Half-life
- ~1 hour
- Evidence
- Human studies
- Route
- SubQ injection
- Dosing
- Daily SubQ
- Half-life
- ~1 hour
- Evidence
- Human studies
- Route
- SubQ injection
- Dosing
- Daily or EOD
- Half-life
- Unknown in humans
- Evidence
- Human studies
- Route
- SubQ injection
- Dosing
- Daily SubQ injection.
- Half-life
- ~3-4 hours
- Evidence
- Human studies
- Route
- Oral
- Dosing
- Daily, before bed
- Half-life
- ~24 hours
- Evidence
- Human studies
- Route
- SubQ injection, IM injection, Oral (less studied)
- Dosing
- Once or twice daily
- Half-life
- ~4–6 hours
- Evidence
- Human studies
- Route
- SubQ injection, Topical application, IM injection
- Dosing
- Daily
- Half-life
- Not measured in humans
- Evidence
- Human studies
- Route
- SubQ injection, IM injection
- Dosing
- 2x/week loading, 1–2mg/week maintenance
- Half-life
- ~0.5–2 hours
- Evidence
- Human studies
- Route
- SubQ injection, IM injection
- Dosing
- Weekly
- Half-life
- ~0.5–2 hours
- Evidence
- Animal or lab
- Route
- SubQ injection
- Dosing
- Daily, fasted
- Half-life
- ~30 min
- Evidence
- Animal or lab
- Route
- SubQ injection
- Dosing
- Daily
- Half-life
- ~20 minutes
- Evidence
- Animal or lab
- Route
- Oral, Topical (DMSO carrier)
- Dosing
- Daily (cycle 4–8 weeks)
- Half-life
- Very long
- Evidence
- Animal or lab
- Route
- SubQ injection
- Dosing
- Daily
- Half-life
- Short
- Evidence
- Animal or lab
- Route
- SubQ injection, Oral capsules
- Dosing
- Daily
- Half-life
- Unknown
- Evidence
- Animal or lab
- Route
- SubQ injection, IM injection
- Dosing
- 2–3x weekly, post-workout
- Half-life
- Not measured: no pharmacokinetic study of PEG-MGF has been published, in people or in animals. The unmodified peptide is broken down quickly, and for a mouse heart study researchers stabilized it chemically — amidating one end and swapping two arginines for their mirror-image form
- Evidence
- Reports only
- Route
- SubQ injection
- Dosing
- EOD or twice weekly.
- Half-life
- ~4.5 min
Compared side by side
Guides
Questions
Which peptides have been studied in people for injury recovery and healing?
9 of the 16 on this page: Teriparatide, Abaloparatide, LL-37, HGH, MK-677, BPC-157, GHK-Cu, TB-500 and Thymosin Beta-4. The rest have animal or lab evidence or community reports only.
Is any peptide FDA-approved for injury recovery and healing?
No. None of the 16 compounds on this page has an FDA approval for a use related to injury recovery and healing in its library entry.
Which is the best-studied peptide for injury recovery and healing?
By our count, Teriparatide, with 3 study pages in people about injury recovery and healing, the most of any compound here.
Which ones have only animal or lab evidence for injury recovery and healing?
6 compounds: AOD-9604 (rabbits), ARA-290 (rats), Dihexa (rats), SS-31 (mice), Cartalax and PEG-MGF. A result in animals or cells often doesn’t hold in people.
How are the peptides for injury recovery and healing taken?
Of the 16 compounds for injury recovery and healing, 14 are taken by injection, 4 by mouth, 2 on the skin, as their library entries list (some have more than one route). The table above gives each one’s route, how often it is dosed and its half-life.
How do the peptides for injury recovery and healing compare with each other?
We compare 9 pairs of them side by side: BPC-157 vs TB-500, GHK-Cu vs BPC-157, TB-500 vs Thymosin Beta-4, TB-500 vs GHK-Cu, BPC-157 vs Thymosin Beta-4, BPC-157 vs ARA-290, TB-500 vs Ac-SDKP, HGH vs MK-677 and Teriparatide vs Abaloparatide.
How we ranked them
Each compound is placed on the highest rung its evidence for this goal reaches. First come compounds the FDA has approved for a use related to the goal, and only where the library entry says so. Next come compounds studied in people for it (in one of our study pages, or in the trials a research note of the library entry rests on), then those with animal or lab studies only, and last those resting on community reports alone.
Within a rung, compounds are ordered by how many of our study pages in people cover the goal, then by the library’s overall research rating, then by the number of study pages of any kind. A compound is on this page only because its library entry lists a use for this goal, says so in its description, or one of our study pages is about it; the reason is printed with each one.
This is a ranking of evidence, not of results, and not advice on what anyone should take.